Publication | Closed Access
Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes
51
Citations
32
References
2017
Year
Our data suggest the potential of DPP4i to prevent the progressive loss of muscle mass with ageing in patients with type 2 diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1